At least for NKG2A, this explanation seems rather unlikely, as (i) over-expression of NKG2A is not a constant finding in TAP deficiency, and (ii) expression levels diminish in parallel to clinical improvement. This evidence concerns the gene KLRC1 and hyperinsulinemic hypoglycemia, familial, 4.